Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection–response to Guangting Zeng and Yuchi Zhou

Detalles Bibliográficos
Autores principales: Adegunsoye, Ayodeji, Baccile, Rachel, Best, Thomas J., Zaksas, Victoria, Zhang, Hui, Karnik, Rasika, Patel, Bhakti K., Solomonides, Anthony E., Parker, William F., Solway, Julian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565760/
https://www.ncbi.nlm.nih.gov/pubmed/37829195
http://dx.doi.org/10.1016/j.lana.2023.100611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565760/
https://www.ncbi.nlm.nih.gov/pubmed/37829195
http://dx.doi.org/10.1016/j.lana.2023.100611

Ejemplares similares